Advertisement

Parasitology Research

, Volume 97, Supplement 1, pp S11–S16 | Cite as

Influence of the cyclooctadepsipeptides PF1022A and PF1022E as natural products on the design of semi–synthetic anthelmintics such as emodepside

  • R Jeschke
  • K. Iinuma
  • A. Harder
  • M. Schindler
  • T. Murakami
Original Paper

Abstract

The 24–membered cyclooctadepsipeptide (CODP) PF1022A, the active metabolite of the fungus imperfectus Mycelia sterilia (Rosellinia sp.) isolated from the plant Camellia japonica in Japan, is described as a powerful broad–spectrum anthelmintic natural product with low toxicity in animals. Further CODPs such as PF1022B, C, D and E have been isolated from the same culture and their structures have been established. Both PF1022A and PF1022E serve as valuable starting materials for the synthesis of semi–synthetic CODP derivatives with improved intrinsic anthelmintic potency and broad–spectrum activity. It was found that in most cases the di–substituted PF1022A derivatives showed a greater (or equal) activity by oral application against the gastrointestinal nematode Haemonchus contortus compared to the corresponding mono–substituted PF1022A analogues as exemplified by emodepside. In order to get additional information on the bioactive conformation, emodepside was transformed into its mono– and tetra–thionated derivatives by isosteric replacement. In the light of the increased efficacy of these derivatives against H. contortus or Trichostrongylus colubriformis, it has been suggested that the asymmetric conformation clearly influences the anthelmintic activity of CODPs. Although useful synthetic pathways are available today for the preparation of the semi–synthetic CODP emodepside, the fermentative production of its bis–para–nitro and bis–para–amino precursors could be the process used for its industrial–scale production in the future.

Keywords

Anthelmintic Activity Bioactive Conformation Emodepside Phenyllactic Acid PF1022 

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • R Jeschke
    • 1
  • K. Iinuma
    • 2
  • A. Harder
    • 3
  • M. Schindler
    • 1
  • T. Murakami
    • 4
  1. 1.Bayer CropScience AGResearch and Development, Chemistry lnsecticidesMonheim am RheinGermany
  2. 2.Fuji Amide Chemical Company LimitedTokyo 115–0051Japan
  3. 3.Bayer HealthCare AGAnimal Health Division, Research and Development ParasiticidesLeverkusenGermany
  4. 4.Microbiological Resources and Technology LaboratoriesMeiji Seika Kaisha, Ltd.Kanagawa 250–0852Japan

Personalised recommendations